Online Submission will open on 1st August 2018 and close on 1st October 2018 Invitation to submit original, previously unpublished research or audit carried out by your department or group as a poster abstract to BTOG 2019. Accepted abstracts will … Read More
The IASLC is currently involved in a project aiming to gain more information about the prevalence and practices of molecular testing in lung cancer patients throughout the world. “We invite all IASLC members, health care professionals and other interested parties … Read More
The Second Edition of the IASLC Staging Manual in Thoracic Oncology reports on the latest revisions of the tumor, node and metastasis (TNM) classifications of thoracic malignancies, namely, lung cancer, malignant pleural mesothelioma, carcinoma of the esophagus and of the … Read More
Each year the British Thoracic Oncology Group (BTOG) gives a lifetime achievement award to an individual who in the steering committee’s opinion has made a significant contribution to the management of thoracic malignancies in the UK and Ireland. The award … Read More
BTOG distributed this EORTC survey to our members and the resulting article has just been published: Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of … Read More
Download the BTOG Annual Report (April 2016 to March 2017).
Article from the European Journal of Cancer: Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial Please see article.
ASCO 2017 National Update – Roy Castle Lung Cancer Foundation in partnership with BTOG Friday 9th June 2017 – Wellcome Collection, London The main focus for this Roy Castle Lung Castle Foundation meeting, planned in partnership with the British Thoracic … Read More
The BTOG Position Statement 2016 is now available. This document provides the brief background of BTOG and achievements to date and confirms BTOG’s Core Principles and Key Activities. Please view here. 784018778_British Thoracic Oncology Group Position Statement Final Dec 2016
Dr Sanjay Popat is Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London. Dr Popat has published in … Read More